Profile of:

Lennart Jacobsson

Publications on axial SPA or PSA 2018-: 199. Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Risk of Cardiac Rhythm Disturbances and Aortic Regurgitation in Different Spondyloarthritis Subtypes in Comparison to General Population – a register-based study from Sweden. Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19.PMID: 29259045 202. van Lunteren M, Ez-Zaitouni Z, de Koning A, Dagfinrud H, Ramonda R, Jacobsson L, Landewé R, van der Heijde D, van Gaalen FA. In early axial spondyloarthritis increasing disease activity is associated with worsening of health-related quality of life over time. J Rheumatol. 2018 Jun;45(6):779-784. doi: 10.3899/jrheum.170796. Epub 2018 Mar 15. 204. Ez-Zaitouni Z, Landewé R, van Lunteren M, Bakker P.A.C., Fagerli K.M., Ramonda R, Jacobsson LTH, van der Heijde D, van Gaalen F. Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive. Rheumatology (Oxford). 2018 Jul 1;57(7):1173-1179. doi: 10.1093/rheumatology/key035.PMID: 29579265 207. Glintborg B, Lindström U, Aaltonen K, Kristianslund EK, Gudbjornsson B, Chatzidionysiou K, Askling J, Nordström D, Hetland ML, Di Giuseppe D, Dreyer L, Kristensen LE, Schjødt Jørgensen T, Eklund K, Grondal G, Ernestam S, Joensuu J, Törmänen,MRK, Skydsgaard H, Hagfors J, Kvien TK, Lie E, Fagerli KM, Geirsson AJ, Jonsson H, Provan SA, Krogh NS, Jacobsson LTH. Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016 A collaboration between five biological registries. Scand J Rheumatol. 2018 Nov;47(6):465-474. doi: 10.1080/03009742.2018.1444199. Epub 2018 Aug 2.PMID: 30070923 216. Deminger A, Klingberg E, Geijer M, Göthlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d'Elia H. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis. Arthritis Res Ther. 2018 Aug 3;20(1):162. doi: 10.1186/s13075-018-1665-1. 221. Law L, Beckman Rehnman J, Deminger A, Klingberg E, Jacobsson LTH, Forsblad-d'Elia H. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex. Arthritis Res Ther. 2018 Dec 27;20(1):284. doi: 10.1186/s13075-018-1784-8. PMID:30587228 222..Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, Forsblad-d'Elia H6, Carlsten H, Eliasson B, Larsson I. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther. 2019 Jan 11;21(1):17. doi: 10.1186/s13075-019-1810-5. 225. de Hooge M, van Gaalen FA, Renson T, De Craemer AS, van de Sande MG, Ramonda R, Fagerli KM, Jacobsson LTH, van der Heijde D, Elewaut D, Van den Bosch F. Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study. Ann Rheum Dis. 2019 Nov;78(11):1605-1606. 228. Ortolan A, van Lunteren M, Ramiro S, S Ramiro , R Ramonda, R Landewé, H Dagfinrud, LTH Jacobsson, D van der Heijde, FA van Gaalen. Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort. Arthritis Res Ther. 2018;20(1):218. Published 2018 Oct 1. doi:10.1186/s13075-018-1705-x 229. Dehlin M, Landgren AJ, Bergsten U, Jacobsson LTH. The Validity of Gout Diagnosis in Primary Care: Results from a Patient Survey. J Rheumatol. 2019;46(11):1531–1534. 230. Lindström U, Glintborg B, Di Giuseppe D, D Nordström , S Aarrestad Provan , B Gudbjornsson, J Askling, M Lund Hetland, K Aaltonen, N Steen Krogh, AJ Geirsson, LTH Jacobsson . Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis. RMD Open. 2019;5:e001079. Published 2019 Oct 23. doi:10.1136/rmdopen-2019-001079 231. Bengtsson K, Klingberg E, Deminger A, H Wallberg, LTH Jacobsson, L Bergfeldt, H Forsblad-d'Elia. Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study. RMD Open. 2019;5(2):e001053. Published 2019 Nov 13. doi:10.1136/rmdopen-2019-001053 232. van Lunteren M, van der Heijde D, Sepriano A, IJ Berg, M Dougados, L Gossec, L Jacobsson, R Ramonda, M Rudwaleit, J Sieper, R Landewé , FA van Gaalen. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?. Rheumatology (Oxford). 2019;58(9):1649–1654. doi:10.1093/rheumatology/kez095 doi:10.1111/sji.12792 234. Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML. Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. Rheumatology (Oxford). 2020 Jul 1;59(7):1640-1650. doi: 10.1093/rheumatology/kez427. PMID: 31665497 236. Landgren AJ, Bilberg A, Eliasson B, I Larsson, M Dehlin, LTH Jacobsson, E Klingberg. Cardiovascular risk factors are highly overrepresented in Swedish patients with psoriatic arthritis compared with the general population [published online ahead of print, 2019 Oct 21]. Scand J Rheumatol. 2019;1–5. doi:10.1080/03009742.2019.1672783 239. Michelsen B, Ørnbjerg LM, Kvien TK, K Pavelka, MJ Nissen, D Nordström, MJ Santos, SS Koca , J Askling , Z Rotar , B Gudbjornsson, C Codreanu, AG Loft, EK Kristianslund, HF Mann, A Ciurea, KK Eklund, E Vieira-Sousa, A Yazici, L Jacobsson, M Tomšič, TJ Löve, R Ionescu , I E van der Horst-Bruinsma, F Iannone, M Pombo-Suarez, GT Jones, LH Hyldstrup, NS Krogh, M Lund Hetland , Mikkel Østergaard. Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis [published online ahead of print, 2020 Jan 20]. Rheumatology (Oxford). 2020;kez656. doi:10.1093/rheumatology/kez656 240. Lindström U, Glintborg B, Di Giuseppe D, Schjødt Jørgensen T, Gudbjornsson B, Lederballe Grøn K, Aarrestad Provan S, Michelsen B, Lund Hetland M, Wallman JK, Nordström D, Trokovic N, Love TJ, Krogh NS, Askling J, Jacobsson LTH, Kristensen LE. Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Rheumatology (Oxford). 2020 Dec 26:keaa825. doi: 10.1093/rheumatology/keaa825. Online ahead of print.PMID: 33367900 243. Landgren AJ, Bilberg A, Eliasson B, Larsson I, Dehlin M, Jacobsson L, Klingberg E. Cardiovascular risk factors are highly overrepresented in Swedish patients with psoriatic arthritis compared with the general population. Scand J Rheumatol. 2020 May;49(3):195-199. doi: 10.1080/03009742.2019.1672783. Epub 2019 Oct 21. PMID: 31631735 247. Deminger A, Klingberg E, Nurkkala M, Geijer M, Carlsten H, Jacobsson LTH, Forsblad-d'Elia H. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis. Rheumatology (Oxford). 2020 Oct 27:keaa460. doi: 10.1093/rheumatology/keaa460. Online ahead of print. PMID: 33106846 248. Bengtsson K, Forsblad-d'Elia H, Deminger A, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study. Rheumatology (Oxford). 2020 Nov 20:keaa692. doi: 10.1093/rheumatology/keaa692. Online ahead of print.PMID: 33216939 249. Södergren A, Askling J, Bengtsson K, Forsblad-d'Elia H, Jernberg T, Lindström U, Ljung L, Mantel Ä, Jacobsson LTH. Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis. Clin Rheumatol. 2020 Aug 26. doi: 10.1007/s10067-020-05354-3. Online ahead of print.PMID: 32845439 250. Glintborg B, Lindström U, Giuseppe DD, Provan SA, Gudbjornsson B, Hetland ML, Michelsen B, Wallman JK, Aaltonen K, Hokkanen AM, Nordström D, Jørgensen TS, Hansen RL, Geirsson AJ, Grøn KL, Krogh NS, Askling J, Kristensen LE, Jacobsson LTH. One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses. Arthritis Care Res (Hoboken). 2022 May;74(5):748-758. doi: 10.1002/acr.24523. Epub 2022 Mar 8.PMID: 33253491. 252. Lund Hansen R, Schoedt Jørgensen T, Dreyer L, Hetland ML, Glintborg B, Askling J, Di Giuseppe D, Jacobsson LTH, Wallman JK, Nordstrom D, Aaltonen K, Kristianslund EK, Kvien TK, Provan SA, Gudbjornsson B, Love TJ, Kristensen LE Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study. Rheumatology (Oxford). 2021 Jan 5;60(1):140-146. doi: 10.1093/rheumatology/keaa237.PMID: 32591790 256. Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d'Elia H, Jacobsson LTH, Askling J. Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis. 2021 Jun 15:annrheumdis-2021-220420. doi: 10.1136/annrheumdis-2021-220420. 257. Lindström U, Di Giuseppe D, Delcoigne B, Glintborg B, Möller B, Ciurea A, Pombo-Suarez M, Sanchez-Piedra C, Eklund K, Relas H, Gudbjornsson B, Love TJ, Jones GT, Codreanu C, Ionescu R, Nekvindova L, Závada J, Atas N, Yolbas S, Fagerli KM, Michelsen B, Rotar Ž, Tomšič M, Iannone F, Santos MJ, Avila-Ribeiro P, Ørnbjerg LM, Østergaard M, Jacobsson LT, Askling J, Nissen MJ. Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration. .Ann Rheum Dis. 2021 Jun 3:annrheumdis-2021-220097. doi: 10.1136/annrheumdis-2021-220097. Online ahead of print. 258. Exarchou S, Turesson C, Lindström U, Ramonda R, Landewé RBM, Dagfinrud H, van Gaalen F, van der Heijde D, Jacobsson LTH. Lifestyle Factors and Disease Activity over Time in Early Axial Spondyloarthritis - The SPondyloArthritis Caught Early (SPACE) Cohort. J Rheumatol. 2021 Sep 1:jrheum.210046. doi: 10.3899/jrheum.210046. Online ahead of print.PMID: 34470793 260. Deminger A, Klingberg E, Lorentzon M, Hedberg M, Carlsten H, Jacobsson LTH, Forsblad-d'Elia H.Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT. Osteoporos Int. 2021 Jul 14. doi: 10.1007/s00198-021-06049-4. Online ahead of print.PMID: 34263348 264. Exarchou S, Turesson C, Lindström U, Ramonda R, Landewé RB, Dagfinrud H, van Gaalen F, van der Heijde D, Jacobsson LT. Lifestyle Factors and Disease Activity Over Time in Early Axial Spondyloarthritis: The SPondyloArthritis Caught Early (SPACE) Cohort. J Rheumatol. 2022 Apr;49(4):365-372. doi: 10.3899/jrheum.210046. Epub 2021 Sep 1.PMID: 34470793 266. Nissen M, Delcoigne B, Di Giuseppe D, Jacobsson L, Hetland ML, Ciurea A, Nekvindova L, Iannone F, Akkoc N, Sokka-Isler T, Fagerli KM, Santos MJ, Codreanu C, Pombo-Suarez M, Rotar Z, Gudbjornsson B, van der Horst-Bruinsma I, Loft AG, Möller B, Mann H, Conti F, Yildirim Cetin G, Relas H, Michelsen B, Ribeiro PA, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Askling J, Glintborg B, Lindström U.The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. Rheumatology (Oxford). 2022 Mar 22:keac174. doi: 10.1093/rheumatology/keac174. Online ahead of print.PMID: 35323903 269. Wallman JK, Alenius GM, Klingberg E, Sigurdardottir V, Wedrén S, Exarchou S, Lindström U, Di Giuseppe D, Askling J, Jacobsson L Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register. Scand J Rheumatol. 2022 Jun 6:1-11. doi: 10.1080/03009742.2022.2066807. Online ahead of print.PMID: 35659437 270. Di Giuseppe D, Lindström U, Aaltonen K, Relas H, Provan S, Gudbjornsson B, Hetland ML, Askling J, Kauppi M, Geirsson AJ, Chatzidionysiou K, Jørgensen TS, Dreyer L, Michelsen B, Jacobsson L, Glintborg B. The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries. Rheumatology (Oxford). 2022 Aug 30;61(9):3647-3656. doi: 0.1093/rheumatology/keab946.PMID: 34940795 273. Glintborg B, Di Giuseppe D, Wallman JK, Provan SA, Nordström D, Hokkanen AM, Österlund J, Kristianslund E, Kvien TK, Gudbjornsson B, Hetland ML, Michelsen B, Jacobsson L, Askling J, Lindström U. Is the risk of infection higher during treatment with secukinumab than with TNF-inhibitors? An observational study from the Nordic countries. Rheumatology (Oxford). 2022 Jun 20:keac358. doi: 10.1093/rheumatology/keac358. Online ahead of print.PMID: 35723604 275. Di Giuseppe D, Lindström U, Aaltonen K, Relas H, Provan S, Gudbjornsson B, Hetland ML, Askling J, Kauppi M, Geirsson AJ, Chatzidionysiou K, Jørgensen TS, Dreyer L, Michelsen B, Jacobsson L, Glintborg B. The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries. Rheumatology (Oxford). 2022 Aug 30;61(9):3647-3656. doi: 10.1093/rheumatology/keab946.PMID: 34940795 277. Exarchou S, Wallman JK, Di Giuseppe D, Klingberg E, Sigurdardottir V, Wedrén S, Lindström U, Turesson C, Jacobsson LTH, Askling J. The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017. J Rheumatol. 2023 Mar 1:jrheum.221139. doi: 10.3899/jrheum.221139. Online ahead of print.PMID: 36858434